Mark S. Cohen is a founder of Pearl Cohen Zedek Latzer Baratz, a Senior Partner, Chair of the Life Sciences Group, and a member of the firm’s Executive Committee. Mark’s practice focuses on patent prosecution in the pharmaceutical, chemical, biological, and medical device areas, as well as licensing and client counseling. He is well-versed in all aspects of patent prosecution, intellectual property management, strategic advice, technology assessment, and licensing matters. His work includes management of large patent portfolios, negotiating terms, drafting agreements, and counseling start-ups. He has been involved in large due diligence matters; infringement, validity and patentability opinions; licensing matters; European patent opposition proceedings, and US interference and reexamination proceedings.
Mark was a Contributing Editor to the Journal of Biolaw and Business, an Advisory Board Member of the University of Baltimore Intellectual Property Law Journal, a Strategic Advisory Board Member of the University of Pittsburgh Cancer Institute, Chairperson of the Animal Patent Committee, and the Chairperson of the Plant Patent Committee, Intellectual Property Law Section, American Bar Association. He has published in Nature Biotechnology and various patent trade journals. He has lectured at the Practicing Law Institute (PLI) and the American Conference Institute on general patent topics, and at other venues in the US and Europe on patent issues in the biotechnology/ pharmaceutical area. Mark also served as Editor-in-Chief of the University of Baltimore Intellectual Property Law Journal.